Timothy C. Dec serves as the Senior Vice President and Chief Financial Officer at Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. In his role, Dec is responsible for overseeing the financial strategy and operations of the company, ensuring its financial health and growth. He plays a crucial role in guiding Supernus through the complex financial landscape of the pharmaceutical industry, managing aspects such as budgeting, financial reporting, and investor relations. Before joining Supernus Pharmaceuticals, Dec held several high-level financial positions that have equipped him with a robust skill set in corporate finance and strategic planning. He previously served as the CFO at GeoVax Labs, Inc., where he successfully managed the company's financial operations during a critical growth phase. Dec also has experience working with major corporations, including his tenure at Smith & Nephew, where he held various finance roles that enhanced his expertise in global financial management. His educational background includes a Bachelor of Science in Accounting from Villanova University and an MBA from Drexel University, further solidifying his credentials in the field. Under Dec's financial leadership, Supernus Pharmaceuticals has seen significant progress in its mission to deliver innovative treatments to patients. His strategic financial planning has been instrumental in supporting the company's research and development efforts, as well as its expansion into new markets. Dec's ability to navigate the financial complexities of the pharmaceutical industry has been a key factor in Supernus's continued success and growth, making him an invaluable asset to the organization.